BCRX logo

BioCryst Pharmaceuticals, Inc. (BCRX) Debt To Equity Ratio

Annual Debt To Equity:

-1.67+0.11(+6.18%)
December 31, 2024

Summary

  • As of today, BCRX annual debt to equity ratio is -1.67, with the most recent change of +0.11 (+6.18%) on December 31, 2024.
  • During the last 3 years, BCRX annual debt to equity has risen by +3.80 (+69.47%).
  • BCRX annual debt to equity is now -105.17% below its all-time high of 32.33, reached on December 31, 2016.

Performance

BCRX Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXfinancial health metrics

Quarterly Debt To Equity:

0.00+1.73(+100.00%)
June 30, 2025

Summary

  • As of today, BCRX quarterly debt to equity ratio is 0.00, with the most recent change of +1.73 (+100.00%) on June 30, 2025.
  • Over the past year, BCRX quarterly debt to equity has increased by +1.70 (+100.00%).
  • BCRX quarterly debt to equity is now -100.00% below its all-time high of 32.33, reached on December 31, 2016.

Performance

BCRX Quarterly Debt To Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXfinancial health metrics

Debt To Equity Formula

Debt To Equity =  
Total Debt
Shareholders Equity

BCRX Debt To Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+6.2%+100.0%
3Y3 Years+69.5%+100.0%
5Y5 Years-179.9%-100.0%

BCRX Debt To Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+69.5%at high+100.0%
5Y5-Year-179.9%+88.3%-100.0%+100.0%
All-TimeAll-Time-105.2%+97.5%-100.0%+100.0%

BCRX Debt To Equity History

DateAnnualQuarterly
Jun 2025
-
0.00(+100.0%)
Mar 2025
-
-1.73(-3.6%)
Dec 2024
-1.67(+6.2%)
-1.67(+1.8%)
Sep 2024
-
-1.70(0.0%)
Jun 2024
-
-1.70(+0.6%)
Mar 2024
-
-1.71(+3.9%)
Dec 2023
-1.78(+28.5%)
-1.78(+12.3%)
Sep 2023
-
-2.03(+3.8%)
Jun 2023
-
-2.11(+7.5%)
Mar 2023
-
-2.28(+8.4%)
Dec 2022
-2.49(+54.5%)
-2.49(+15.3%)
Sep 2022
-
-2.94(-332.4%)
Jun 2022
-
-0.68(+81.5%)
Mar 2022
-
-3.68(+32.7%)
Dec 2021
-5.47(+61.6%)
-5.47(-397.3%)
Sep 2021
-
-1.10(+25.7%)
Jun 2021
-
-1.48(+27.5%)
Mar 2021
-
-2.04(+85.7%)
Dec 2020
-14.25(-781.8%)
-14.25(-730.5%)
Sep 2020
-
2.26(+115.2%)
Jun 2020
-
1.05(-95.2%)
Mar 2020
-
21.99(+952.2%)
Dec 2019
2.09(+74.2%)
2.09(+208.3%)
Sep 2019
-
-1.93(+77.6%)
Jun 2019
-
-8.61(-346.0%)
Mar 2019
-
3.50(+191.7%)
Dec 2018
1.20(+93.5%)
1.20(+48.1%)
Sep 2018
-
0.81(-23.6%)
Jun 2018
-
1.06(+30.9%)
Mar 2018
-
0.81(+30.6%)
Dec 2017
0.62(-98.1%)
0.62(+21.6%)
Sep 2017
-
0.51(-76.2%)
Jun 2017
-
2.14(+60.9%)
Mar 2017
-
1.33(-95.9%)
Dec 2016
32.33(+5474.1%)
32.33(+154.2%)
Sep 2016
-
12.72(+508.6%)
Jun 2016
-
2.09(+109.0%)
Mar 2016
-
1.00(+72.4%)
Dec 2015
0.58(+45.0%)
0.58(+23.4%)
Sep 2015
-
0.47(+20.5%)
Jun 2015
-
0.39(-17.0%)
Mar 2015
-
0.47(+17.5%)
Dec 2014
0.40(+101.5%)
0.40(+11.1%)
Sep 2014
-
0.36(+9.1%)
Jun 2014
-
0.33(+106.3%)
Mar 2014
-
-5.24(+80.3%)
Dec 2013
-26.64(+59.7%)
-26.64(-402.7%)
Sep 2013
-
8.80(+365.1%)
Jun 2013
-
-3.32(+68.6%)
Mar 2013
-
-10.56(+84.0%)
Dec 2012
-66.08(-3355.2%)
-66.08(-2252.4%)
Sep 2012
-
3.07(+59.9%)
Jun 2012
-
1.92(+47.7%)
Mar 2012
-
1.30(-36.0%)
Dec 2011
2.03(>+9900.0%)
2.03(+76.5%)
Sep 2011
-
1.15(+51.3%)
Jun 2011
-
0.76(+38.2%)
Mar 2011
-
0.55(>+9900.0%)
Dec 2010
0.00(0.0%)
0.00(0.0%)
Sep 2010
-
0.00(0.0%)
Jun 2010
-
0.00(0.0%)
Mar 2010
-
0.00(0.0%)
Dec 2009
0.00
0.00(0.0%)
DateAnnualQuarterly
Sep 2009
-
0.00(0.0%)
Jun 2009
-
0.00(0.0%)
Mar 2009
-
0.00(0.0%)
Dec 2008
0.00(0.0%)
0.00(0.0%)
Sep 2008
-
0.00(0.0%)
Jun 2008
-
0.00(0.0%)
Mar 2008
-
0.00(0.0%)
Dec 2007
0.00(0.0%)
0.00(0.0%)
Sep 2007
-
0.00(0.0%)
Jun 2007
-
0.00(0.0%)
Mar 2007
-
0.00(0.0%)
Dec 2006
0.00(0.0%)
0.00(0.0%)
Sep 2006
-
0.00(0.0%)
Jun 2006
-
0.00(0.0%)
Mar 2006
-
0.00(0.0%)
Dec 2005
0.00(0.0%)
0.00(0.0%)
Sep 2005
-
0.00(0.0%)
Jun 2005
-
0.00(0.0%)
Mar 2005
-
0.00(0.0%)
Dec 2004
0.00(0.0%)
0.00(0.0%)
Sep 2004
-
0.00(0.0%)
Jun 2004
-
0.00(0.0%)
Mar 2004
-
0.00(0.0%)
Dec 2003
0.00(0.0%)
0.00(0.0%)
Sep 2003
-
0.00(0.0%)
Jun 2003
-
0.00(0.0%)
Mar 2003
-
0.00(0.0%)
Dec 2002
0.00(0.0%)
0.00(0.0%)
Sep 2002
-
0.00(0.0%)
Jun 2002
-
0.00(0.0%)
Mar 2002
-
0.00(0.0%)
Dec 2001
0.00(0.0%)
0.00(0.0%)
Sep 2001
-
0.00(0.0%)
Jun 2001
-
0.00(0.0%)
Mar 2001
-
0.00(0.0%)
Dec 2000
0.00(0.0%)
0.00(0.0%)
Sep 2000
-
0.00(0.0%)
Jun 2000
-
0.00(0.0%)
Mar 2000
-
0.00(0.0%)
Dec 1999
0.00(0.0%)
0.00(0.0%)
Sep 1999
-
0.00(0.0%)
Jun 1999
-
0.00(0.0%)
Mar 1999
-
0.00(0.0%)
Dec 1998
0.00(0.0%)
0.00(0.0%)
Sep 1998
-
0.00(0.0%)
Jun 1998
-
0.00(0.0%)
Mar 1998
-
0.00(0.0%)
Dec 1997
0.00(-100.0%)
0.00(0.0%)
Sep 1997
-
0.00(-100.0%)
Jun 1997
-
0.01(0.0%)
Mar 1997
-
0.01(0.0%)
Dec 1996
0.01(-80.0%)
0.01(0.0%)
Sep 1996
-
0.01(-50.0%)
Jun 1996
-
0.02(-33.3%)
Mar 1996
-
0.03(-40.0%)
Dec 1995
0.05(-37.5%)
0.05(0.0%)
Sep 1995
-
0.05(+25.0%)
Jun 1995
-
0.04(-50.0%)
Mar 1995
-
0.08(0.0%)
Dec 1994
0.08
0.08(+14.3%)
Sep 1994
-
0.07(-22.2%)
Jun 1994
-
0.09(+12.5%)
Mar 1994
-
0.08

FAQ

  • What is BioCryst Pharmaceuticals, Inc. annual debt to equity ratio?
  • What is the all-time high annual debt to equity for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. annual debt to equity year-on-year change?
  • What is BioCryst Pharmaceuticals, Inc. quarterly debt to equity ratio?
  • What is the all-time high quarterly debt to equity for BioCryst Pharmaceuticals, Inc.?
  • What is BioCryst Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?

What is BioCryst Pharmaceuticals, Inc. annual debt to equity ratio?

The current annual debt to equity of BCRX is -1.67

What is the all-time high annual debt to equity for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high annual debt to equity ratio is 32.33

What is BioCryst Pharmaceuticals, Inc. annual debt to equity year-on-year change?

Over the past year, BCRX annual debt to equity ratio has changed by +0.11 (+6.18%)

What is BioCryst Pharmaceuticals, Inc. quarterly debt to equity ratio?

The current quarterly debt to equity of BCRX is 0.00

What is the all-time high quarterly debt to equity for BioCryst Pharmaceuticals, Inc.?

BioCryst Pharmaceuticals, Inc. all-time high quarterly debt to equity ratio is 32.33

What is BioCryst Pharmaceuticals, Inc. quarterly debt to equity year-on-year change?

Over the past year, BCRX quarterly debt to equity ratio has changed by +1.70 (+100.00%)
On this page